Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Y Cho

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The American Journal of Psychiatry|July 3, 2015
In vivo measurement of GABA transmission in healthy subjects and schizophrenia patientsW Gordon Frankle, Raymond Y Cho, Konasale M Prasad, et al.
Plos One|March 3, 2012
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levelsW Gordon Frankle, Raymond Y Cho, N Scott Mason, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
Psychoneuroendocrinology|July 1, 2019
Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophreniaMei Hong Xiu, Dong Mei Wang, Xiang Dong Du, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 9, 2020
Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with SchizophreniaMei Hong Xiu, XiaoE Lang, Da Chun Chen, et al.
Scientific Reports|October 24, 2020
Author Correction: Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorderBo Cao, Qinghua Luo, Yixiao Fu, et al.
Scientific Reports|April 5, 2018
Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorderBo Cao, Qinghua Luo, Yixiao Fu, et al.
Orphanet Journal of Rare Diseases|January 9, 2019
Loss-of-function mutation in inositol monophosphatase 1 (IMPA1) results in abnormal synchrony in resting-state EEGChristopher P Walker, Andre L S Pessoa, Thalita Figueiredo, et al.
Elife|October 30, 2020
A low affinity <i>cis</i>-regulatory BMP response element restricts target gene activation to subsets of Drosophila neuronsAnthony Je Berndt, Katerina M Othonos, Tianshun Lian, et al.
Journal of Psychopharmacology (Oxford, England)|March 12, 2016
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophreniaRagy R Girgis, Jared X Van Snellenberg, Andrew Glass, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The American Journal of Psychiatry|July 3, 2015
In vivo measurement of GABA transmission in healthy subjects and schizophrenia patientsW Gordon Frankle, Raymond Y Cho, Konasale M Prasad, et al.
Plos One|March 3, 2012
[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levelsW Gordon Frankle, Raymond Y Cho, N Scott Mason, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 11, 2008
Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjectsW Gordon Frankle, Raymond Y Cho, Rajesh Narendran, et al.
Psychoneuroendocrinology|July 1, 2019
Interaction of BDNF and cytokines in executive dysfunction in patients with chronic schizophreniaMei Hong Xiu, Dong Mei Wang, Xiang Dong Du, et al.
Cerebral Cortex (New York, N.Y. : 1991)|September 9, 2020
Cognitive Deficits and Clinical Symptoms with Hippocampal Subfields in First-Episode and Never-Treated Patients with SchizophreniaMei Hong Xiu, XiaoE Lang, Da Chun Chen, et al.
Scientific Reports|October 24, 2020
Author Correction: Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorderBo Cao, Qinghua Luo, Yixiao Fu, et al.
Scientific Reports|April 5, 2018
Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorderBo Cao, Qinghua Luo, Yixiao Fu, et al.
Orphanet Journal of Rare Diseases|January 9, 2019
Loss-of-function mutation in inositol monophosphatase 1 (IMPA1) results in abnormal synchrony in resting-state EEGChristopher P Walker, Andre L S Pessoa, Thalita Figueiredo, et al.
Elife|October 30, 2020
A low affinity <i>cis</i>-regulatory BMP response element restricts target gene activation to subsets of Drosophila neuronsAnthony Je Berndt, Katerina M Othonos, Tianshun Lian, et al.
Journal of Psychopharmacology (Oxford, England)|March 12, 2016
A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophreniaRagy R Girgis, Jared X Van Snellenberg, Andrew Glass, et al.
Pageof 6